|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Depot testosterone with etonogestrel implants result in induction of |
| azoospermia in all men for long-term contraception. |
| Brady BM; Walton M; Hollow N; Kicman AT; Baird DT |
| Human Reproduction. 2004;19(11):2658-2667. |
| Combined testosterone and progestogen preparations are a promising approach to male hormonal contraception. We |
| investigated the effect of s.c. etonogestrel with depot testosterone on spermatogenesis in normal men over a period |
| of 48 weeks. Fifteen healthy men received three s.c. 68mg etonogestrel implants. Testosterone pellets (400 mg) were |
| administered at 12 weekly intervals. Nine men completed 48 weeks of treatment. Four subjects chose to discontinue |
| after 6 months, one man withdrew from the study early for personal reasons and one was withdrawn due to illness. |
| Sperm concentrations of <1 x 10/6/ml were achieved in all men by 16 weeks of treatment. All men became |
| azoospermic, although the time to achieve this varied from 8 to 28 weeks. Azoospermia was maintained in eight of |
| the nine men treated for 48 weeks, one subject showing partial recovery from 40 weeks. Testosterone levels |
| remained in the physiological range throughout. Treatment did not result in weight gain, change in body composition |
| or decline in high-density lipoprotein cholesterol concentrations. The combination of three etonogestrel implants |
| with depot testosterone results in rapid and consistent suppression of spermatogenesis. This can be maintained for |
| up to 1 year and may therefore be a suitable approach for a long-acting male hormonal contraceptive. (PubHealth.info |
| Document ID: CONT1T 523-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Depot testosterone with etonogestrel implants result in |
| induction of azoospermia in all men for long-term contraception.", is(are) Brady BM; Walton M; Hollow N; Kicman |
| AT; Baird DT. The source of this article is "Human Reproduction. 2004;19(11):2658-2667.". This article was |
| published in 2004 in English language(s). (PubHealth.info® Document ID: CONT1T 523-06. All rights reserved with |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |